期刊文献+

主动脉内球囊反搏联合血栓抽吸术治疗大面积ST段抬高型急性心肌梗死的疗效观察

Therapeutic Effect of Intra Aortic Balloon Counterpulsation Combined with Thrombotic Aspiration in the Treatment of Large Area ST Segment Elevation Acute Myocardial Infarction
下载PDF
导出
摘要 目的研究主动脉内球囊反搏联合血栓抽吸术对大面积ST段抬高型急性心肌梗死患者心功能及预后的影响,观察其临床疗效。方法选取2016年5月~2017年1月我院大面积ST段抬高型急性心肌梗死患者80例,按照随机抽签方式分为对照组和观察组,各40例。对照组采取予以血栓抽吸术治疗,观察组予以主动脉内球囊反搏联合血栓抽吸术治疗,比较两组术后肺动脉楔压(PCWP)、心输出量(CO)、平均动脉压(MABP)、心肌钙蛋白(CTn I)峰值及肌酸激酶同工酶(CK-MB)峰值水平及心功能改善情况。结果观察组CO高于对照组,差异有统计学意义(P<0.05);观察组MABP高于对照组[(55.38±10.76)mm Hg vs(42.79±11.08)mm Hg],差异有统计学意义(P<0.05);观察组PCWP低于对照组[(9.41±6.65)mm Hg vs(18.33±7.56)mm Hg],差异有统计学意义(P<0.05);CTn I及CK-MB峰值水平观察组均低于对照组[(0.34±0.06)μg/L vs(0.51±0.15)μg/L、(105.19±10.78)U/L vs(151.64±15.72)U/L],差异有统计学意义(P<0.05);术后6个月观察组LVEF优于对照组[(43.27±6.37)%vs(39.85±5.96)%],差异有统计学意义(P<0.05);术后6个月观察组LVESD、LVEDD水平均低于对照组,差异有统计学意义(P<0.05)。结论与血栓抽吸术相比,主动脉内球囊反搏联合血栓抽吸术可进一步改善患者心功能,且预后良好,值得临床应用。 Objective To study the effects of intra-aortic balloon counterpulsation combined with thrombotic aspiration on cardiac function and prognosis in patients with large ST segment elevation acute myocardial infarction.Methods 80 patients with large area ST segment elevation acute myocardial infarction from May 2016 to January 2017 were randomly divided into control group and observation group with 40 cases each.The control group was treated with thrombotic aspiration,and the observation group was treated with intraaortic balloon pump combined with thrombotic aspiration.The peak values of pulmonary wedge pressure(PCWP),cardiac output(CO),mean arterial blood pressure(MABP),cardiac troponin I(CTnI),creatine kinase isoenzyme(CK-MB)and cardiac function were compared between the two groups.Results The observation group CO was higher than the control group,the difference was statistically significant(P<0.05);the observation group MABP was higher than the control group[(55.38±10.76)mmHg vs(42.79±11.08)mmHg],the difference was statistically significant(P<0.05);PCWP in observation group was lower than that in control group[(9.41±6.65)mmHg vs(18.33±7.56)mmHg],the difference was statistically significant(P<0.05);The peak levels of CTnI and CK-MB were lower in the observation group than in the control group[(0.34±0.06)μg/L vs(0.51±0.15)μg/L,(105.19±10.78)U/Lvs(151.64±15.72)U/L],the difference was statistically significant(P<0.05);LVEF in the observation group was better than that in the control group[(43.27±6.37)%vs(39.85±5.96)%]at 6 months postoperatively,and the difference was statistically significant(P<0.05).The level of LVESD and LVEDD in the observation group was lower than that in the control group at 6 months after operation,the difference was statistically significant(P<0.05).Conclusion Compared with thrombotic aspiration,intra-aortic balloon counterpulsation combined with thrombotic aspiration can further improve the cardiac function of the patients,and the prognosis is good,which is worthy of clinical application.
作者 毛红岩 MAO Hong-yan(Department of Cardiology,Jiamusi Central Hospital,Jiamusi 154002,Heilongjiang,China)
出处 《医学信息》 2018年第7期98-100,共3页 Journal of Medical Information
关键词 主动脉内球囊反搏术 血栓抽吸术 大面积ST段抬高型急性心肌梗死 心功能 Intraaortic balloon counterpulsation Thrombotic aspiration Large area ST segment elevation acute myocardial infarction Cardiac function
  • 相关文献

参考文献7

二级参考文献99

  • 1刘中民,朱洪生,周嘉,张有荣,朱木兰,张敏.心脏自主神经变化与再灌注损伤关系的研究[J].中华胸心血管外科杂志,1995,11(3):169-171. 被引量:7
  • 2王小艳.急性冠脉综合征后6个月死亡和心肌梗死的预测:前瞻性的多国观察性研究(GRACE)[J].中国处方药,2006(11):25-26. 被引量:138
  • 3Raber L, Windecker S. Primary percutaneous coronary intervention and risk of stent thrombosis: a look beyond the HORIZON [ J ]. Circulation, 2011, 123 (16).: 1709-1712.
  • 4De Luca G, Navarese E, Marino P. Risk profile and benefits from Gp IIb - HI a inhibitors among patients with ST - segment elevation myocardial infarction treated with primary angioplasty: a meta- regression analysis of randomized trials [ J ]. Eur Heart J, 2009, 30 (22) : 2705 -2713.
  • 5Picker SM. Antiplatelet therapy in the prevention of coronary syndromes: mode of action, benefits, drawbacks [J]. Cardiovasc Hematol Agents Med Chem, 2013, 11 (1) : 49 -57.
  • 6Task Force on the management of ST - segment elevation acute myocardial infarction of the European Society of Cardiology ( ESC ) , Steg PG, James SK, et al. ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST - segment elevation [J]. Eur Heart J, 2012, 33 (20): 2569-2619.
  • 7O'Gara PT, Kushner FG, Ascheim DD, et al. 2013 ACCF/AHA guideline for the management of ST - elevation myocardial infarction: a report of the American College of Cardiology Foundation/American HeartAssociation Task Force on Practice Guidelines [ J ]. Circulation, 2013, 127 (4): e362-425.
  • 8Tcheng JE, Kandzari DE, Grines CL, et al. Benefits and risks ofabciximab use in primary angioplasty for acute myocardial infarction: the Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications ( CADILLAC ) trial [ J ]. Circulation, 2003, 108 (11): 1316-1323.
  • 9Yokoyama K, Daida H. Selective coronary angiography [ J ]. Nihon Rinsho, 2011, 69 (Suppl7): 206-215.
  • 10Chesebro JH, Knatterud G, Roberts R, et al. Thrombolysis in Myocardial Infarction (TIMI) Trial, Phase I: A comparison between intravenous tissue plasminogen activator and intravenous streptokinase. Clinical findings through hospital discharge [ J ]. Circulation, 1987, 76 (1) : 142 - 154.

共引文献113

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部